Greg E. Reckless

Dissociation between In Vivo Occupancy and Functional Antagonism of Dopamine D2 Receptors: Comparing Aripiprazole to Other Antipsychotics in Animal Models

Sridhar Natesan, Greg E. Reckless, José N. Nóbrega et al. · Neuropsychopharmacology · 2005 · 194 citations · Full text

Psychiatry, Addiction, Medicine +13

Less Is More: Antipsychotic Drug Effects Are Greater with Transient Rather Than Continuous Delivery

Anne‐Noël Samaha, Greg E. Reckless, Philip Seeman et al. · Biological Psychiatry · 2008 · 112 citations

Psychiatry, Addiction, Psychotropic Medication +8

The Dopamine Stabilizers (S)-(-)-(3-Methanesulfonyl-phenyl)-1-propyl-piperidine [(-)-OSU6162] and 4-(3-Methanesulfonylphenyl)-1-propyl-piperidine (ACR16) Show High in Vivo D2 Receptor Occupancy, Antipsychotic-Like Efficacy, and Low Potential for Motor Side Effects in the Rat

Sridhar Natesan, Kjell Svensson, Greg E. Reckless et al. · Journal of Pharmacology and Experimental Therapeutics · 2006 · 77 citations

Amisulpride the ‘atypical’ atypical antipsychotic — Comparison to haloperidol, risperidone and clozapine

Sridhar Natesan, Greg E. Reckless, Karren B.L. Barlow et al. · Schizophrenia Research · 2008 · 72 citations

Psychiatry, Psychotic Disorder, Psychotropic Medication +10

The antipsychotic potential of l-stepholidine—a naturally occurring dopamine receptor D1 agonist and D2 antagonist

Sridhar Natesan, Greg E. Reckless, Karen B.L. Barlow et al. · Psychopharmacology · 2008 · 56 citations

Molecular Pharmacology, Psychoactive Drug, Psychiatry +9